Michael R. Megna - 01 Sep 2022 Form 4 Insider Report for Kiniksa Pharmaceuticals, Ltd. (KNSA)

Role
CHIEF ACCOUNTING OFFICER
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Issuer symbol
KNSA
Transactions as of
01 Sep 2022
Net transactions value
+$4,112
Form type
4
Filing time
06 Sep 2022, 16:08:30 UTC
Previous filing
11 Apr 2022
Next filing
06 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Common Share Award $6,721 +703 +12% $9.56 6,744 15 Jul 2022 Direct F1
transaction KNSA Class A Common Share Options Exercise +775 +11% 7,519 02 Sep 2022 Direct F2
transaction KNSA Class A Common Share Tax liability $2,608 -228 -3% $11.44 7,291 02 Sep 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Share Option Award $0 +31,460 $0.000000 31,460 01 Sep 2022 Class A Common Share 31,460 $11.97 Direct F3
transaction KNSA Restricted Share Unit Award $0 +15,730 $0.000000 15,730 01 Sep 2022 Class A Common Share 15,730 Direct F2, F4
transaction KNSA Restricted Share Unit Options Exercise $0 -775 -25% $0.000000 2,323 02 Sep 2022 Class A Common Share 775 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 16, 2022 to July 15, 2022. The acquisition of such shares was exempt pursuant to Rule 16b-3(c).
F2 Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
F3 The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022.
F4 The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.
F5 The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021.